Abstract
Epidemiological and experimental studies have shown that the peri-conception period, pregnancy, and infancy are windows of particular sensibility to environmental clues which influence lifelong trajectories across health and disease. Nutrition, stress, and toxins induce epigenetic marks that control long-term gene expression patterns and can be transmitted transgenerationally. Chronic diseases of adulthood such as hypertension, diabetes, and obesity thus have early, developmental origins in the perinatal period. The early epigenome, in interaction with other actors such as the microbiome, add powerful layers of diversity to the biological predisposition generated by the genome. Such “programming” is a normal, adaptive component of development, including in normal pregnancies and births. However, perinatal disease, either maternal (such as pre-eclampsia, ges-tational diabetes, or inflammatory disease) or fetal, and neonatal diseases (such as intrauterine growth restriction and preterm birth) are major conditions of altered programming, translated into an increased risk for chronic disease in these patients when they reach adulthood. Early prevention, optimal perinatal nutrition, and specific follow-up measures are key factors in the early preservation of long-term health.
References
1.
Vassallo PF, Simoncini S, Ligi I, Chateau AL, Bachelier R, Robert S, et al: Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expression. Blood 2014; 123: 2116–2126.
2.
Boubred F, Delamaire E, Buffat C, Daniel L, Boquien CY, Darmaun D, et al: High protein intake in neonatal period induces glomerular hypertrophy and sclerosis in adulthood in rats born with IUGR. Pediatr Res 2016; 79: 22–26.
3.
Boubred F, Daniel L, Buffat C, Tsimaratos M, Oliver C, Lelievre-Pegorier M, et al: The magnitude of nephron number reduction mediates intrauterine growth-restriction-induced long term chronic renal disease in the rat. A comparative study in two experimental models. J Transl Med 2016; 14: 331.
4.
Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ: Weight in infancy and death from ischaemic heart disease. Lancet 1989; 2: 577–580.
5.
Tam WH, Ma RCW, Ozaki R, Li AM, Chan MHM, Yuen LY, et al: In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care 2017; 40: 679–686.
6.
Mitanchez D, Burguet A, Simeoni U: Infants born to mothers with gestational diabetes mellitus: mild neonatal effects, a long-term threat to global health. J Pediatr 2014; 164: 445–450.
7.
Group HSCR, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991–2002.
8.
Valent AM, Hall ES, DeFranco EA: The influence of obesity on perinatal outcomes in pregnancies achieved with assisted reproductive technology: a population-based retrospective cohort study. Obstet Med 2016; 9: 34–39.
9.
Yzydorczyk C, Comte B, Huyard F, Cloutier A, Germain N, Bertagnolli M, et al: Developmental programming of eNOS uncoupling and enhanced vascular oxidative stress in adult rats after transient neonatal oxygen exposure. J Cardiovasc Pharmacol 2013; 61: 8–16.
10.
Marino M, Beny JL, Peyter AC, Diaceri G, Tolsa JF: Perinatal hypoxia enhances cyclic adenosine monophosphate-mediated BKCa channel activation in adult murine pulmonary artery. J Cardiovasc Pharmacol 2011; 57: 154–165.
11.
Hovi P, Vohr B, Ment LR, Doyle LW, McGarvey L, Morrison KM, et al: Blood pressure in young adults born at very low birth weight. Adults Born Preterm International Collaboration. Hypertension 2016; 68: 880–887.
12.
Saigal S, Stoskopf B, Streiner D, Paneth N, Pinelli J, Boyle M: Growth trajectories of extremely low birth weight infants from birth to young adulthood: a longitudinal, population-based study. Pediatr Res 2006; 60: 751–758.
13.
Hack M, Schluchter M, Cartar L, Rahman M: Blood pressure among very low birth weight (< 1.5 kg) young adults. Pediatr Res 2005; 58: 677–684.
14.
Parkinson JR, Hyde MJ, Gale C, Santhakumaran S, Modi N: Preterm birth and the metabolic syndrome in adult life: a systematic review and meta-analysis. Pediatrics 2013; 131: e1240–e1263.
15.
Keijzer-Veen MG, Schrevel M, Finken MJ, Dekker FW, Nauta J, Hille ET, et al: Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. J Am Soc Nephrol 2005; 16: 2762–2768.
16.
Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM, et al: Premature birth and later insulin resistance. N Engl J Med 2004; 351: 2179–2186.
17.
Hovi P, Andersson S, Eriksson JG, Jarvenpaa AL, Strang-Karlsson S, Makitie O, et al: Glucose regulation in young adults with very low birth weight. N Engl J Med 2007; 356: 2053–2063.
18.
Savino F, Lupica MM, Liguori SA, Fissore MF, Silvestro L: Ghrelin and feeding behaviour in preterm infants. Early Hum Devel 2012; 88(suppl 1):S51–S55.
19.
Sonnenschein-van der Voort AM, Arends LR, de Jongste JC, Annesi-Maesano I, Arshad SH, Barros H, et al: Preterm birth, infant weight gain, and childhood asthma risk: a meta-analysis of 147,000 European children. J Allergy Clin Immunol 2014; 133: 1317–1329.
20.
Matheson MC, D Olhaberriague AL, Burgess JA, Giles GG, Hopper JL, Johns DP, et al: Preterm birth and low birth weight continue to increase the risk of asthma from age 7 to 43. J Asthma 2017; 54: 616–623.
21.
Hovi P, Andersson S, Jarvenpaa AL, Eriksson JG, Strang-Karlsson S, Kajantie E, et al: Decreased bone mineral density in adults born with very low birth weight: a cohort study. PLoS Med 2009; 6:e1000135.
22.
Guy A, Seaton SE, Boyle EM, Draper ES, Field DJ, Manktelow BN, et al: Infants born late/moderately preterm are at increased risk for a positive autism screen at 2 years of age. J Pediatr 2015; 166: 269–275 e3.
23.
Carstens LE, Westerbeek EA, van Zwol A, van Elburg RM: Neonatal antibiotics in preterm infants and allergic disorders later in life. Pediatr Allergy Immunol 2016; 27: 759–764.
24.
Swamy GK, Ostbye T, Skjaerven R: Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA 2008; 299: 1429–1436.
25.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913.
26.
Morrison KM, Ramsingh L, Gunn E, Streiner D, Van Lieshout R, Boyle M, et al: Cardiometabolic health in adults born premature with extremely low birth weight. Pediatrics 2016; 138:e20160515.
27.
Abitbol CL, Rodriguez MM: The long-term renal and cardiovascular consequences of prematurity. Nature Rev Nephrol 2012; 8: 265–274.
28.
Arabin B, Baschat AA: Pregnancy: an underutilized window of opportunity to improve long-term maternal and infant health-an appeal for continuous family care and inter-disciplinary communication. Front Pediatr 2017; 5: 69.
29.
Garovic VD, August P: Preeclampsia and the future risk of hypertension: the pregnant evidence. Curr Hypertens Rep 2013; 15: 114–121.
30.
Tauzin L, Rossi P, Grosse C, Boussuges A, Frances Y, Tsimaratos M, et al: Increased systemic blood pressure and arterial stiffness in young adults born prematurely. J Dev Orig Health Dis 2014; 5: 448–452.
31.
Grandvuillemin I, Boubred F, Lamy E, Fromonot J, Charpiot P, Simoncini S, et al: Arginase up-regulation and eNOS uncoupling contribute to impaired endothelium-dependent vasodilation in a rat model of intrauterine growth restriction. Am J Physiol-Regul Integr Comp Physiol, submitted.
32.
Ligi I, Simoncini S, Tellier E, Vassallo PF, Sabatier F, Guillet B, et al: A switch toward angiostatic gene expression impairs the angiogenic properties of endothelial progenitor cells in low birth weight preterm infants. Blood 2011; 118: 1699–1709.
33.
Simoncini S, Chateau AL, Robert S, Todorova D, Yzydorzick C, Lacroix R, et al: Biogenesis of pro-senescent microparticles by endothelial colony forming cells from premature neonates is driven by SIRT1-dependent epigenetic regulation of MKK6. Sci Rep 2017; 7: 8277.
34.
Todd N, Valleron AJ, Bougneres P: Prenatal loss of father during World War One is predictive of a reduced lifespan in adulthood. Proc Natl Acad Sci USA 2017; 114: 4201–4206.
35.
Yzydorczyk C, Li N, Chehade H, Mosig D, Bidho M, Keshavjee B, et al: Transient postnatal overfeeding causes liver stress-induced premature senescence in adult mice. Sci Rep 2017; 7: 12911.
36.
Li N, Guenancia C, Rigal E, Hachet O, Chollet P, Desmoulins L, et al: Short-term moderate diet restriction in adulthood can reverse oxidative, cardiovascular and metabolic alterations induced by postnatal overfeeding in mice. Sci Rep 2016; 6: 30817.
37.
Lloyd-Price J, Abu-Ali G, Huttenhower C: The healthy human microbiome. Genome Med 2016; 8: 51.
38.
Rupaimoole R, Slack FJ: MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 2017; 16: 203–222.
39.
Vinci G, Buffat C, Simoncini S, Boubred F, Ligi I, Dumont F, et al: Gestational age-related patterns of AMOT methylation are revealed in preterm infant endothelial progenitors. PLoS One 2017; 12:e0186321.
40.
Nugent R, Brouwer E: Economic benefit-cost analysis of select secondary prevention interventions in LMIC. Glob Heart 2015; 10: 319–321.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
